Scaling Smart: Strengthen Systems Before Expanding 
ECCA and TTEC Release “Visionary Voices” Research on the Future of Contact Centre Sales in Europe ROOKIE Racing and TOYOTA announce participation in 25-hour endurance race in Thailand
TOKYO, Dec 12, 2022 – (JCN Newswire) – ROOKIE Racing Co., Ltd. (ROOKIE Racing) and…
Society Pass (Nasdaq: SOPA) to Present at the #Adapt International Convention 2022 on 13-14 December 2022
SINGAPORE, Dec 12, 2022 – (ACN Newswire) – Society Pass Incorporated (“SoPa”) (Nasdaq: SOPA), Southeast…
insightsoftware Takes Jet Analytics to the Cloud
Adopting a new SaaS model, Jet Analytics Cloud is delivered via Microsoft Azure to provide…
Renesas Wins 2022 “Outstanding Asia-Pacific Semiconductor Company Award” by Global Semiconductor Alliance
TOKYO–(BUSINESS WIRE)–#2022GSAawards–Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced…
Generac Holdings Inc. (GNRC) Shareholder Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Generac Holdings Inc.
SAN DIEGO–(BUSINESS WIRE)–$GNRC #GNRC—The Class: Robbins LLP reminds investors that a shareholder filed a class…
Fujitsu Joins Scholarship Partner Program of Kamiyama Marugoto College of Design, Engineering and Entrepreneurship, Contributes One Billion Yen to Scholarship Fund
TOKYO, Dec 12, 2022 – (JCN Newswire) – Fujitsu today announced that it joined a…
Agios Presents Updated PYRUKYND® (mitapivat) Long-term Extension Data Demonstrating Sustained Clinical Benefits in Adults with Pyruvate Kinase (PK) Deficiency at 64th ASH Annual Meeting and Exposition
– Data Suggest Long-term Treatment with PYRUKYND® in Adults with PK Deficiency is Associated with…
InvesTech Holdings and NTT Jointly Launch Smart Office SaaS Service Platform
HONG KONG, Dec 12, 2022 – (ACN Newswire) – InvesTech Holdings Limited (“InvesTech Holdings”; together…
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
– 89% ORR in TKI-therapy naïve patients; 73% ORR in all evaluable patients with 27-week…
Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs and in vivo Technology Platform with Six Presentations at 2022 ASH Annual Meeting
Transplanted hypoimmune (HIP)-modified allogeneic CD19-targeted CAR T cells control CD19+ tumor cells in fully immunocompetent…
Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients Across a Broad Range of B-Cell Lymphomas at the 64th Annual ASH Meeting
Media Release COPENHAGEN, Denmark; December 11, 2022 Epcoritamab featured in multiple data disclosures, including four…
Press Release: Statement from Sanofi regarding Horizon Therapeutics plc (“Horizon”)
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR…
Ryvu Therapeutics Presents Clinical and Translational Data of RVU120 and SEL24 (MEN1703) at the 2022 American Society of Hematology (ASH) Annual Meeting
RVU120 Demonstrates Single-Agent Activity with a Complete Response, 4 Blast Reductions, and 4 Erythroid and/or Platelet…
Vincerx Pharma Presents Preclinical Data on VIP943 in Acute Myeloid Leukemia Models at the 64th American Society of Hematology Annual Meeting 2022
Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conjugate (ADC),…
IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting
First Preclinical Data for IGM-2644 and IGM-2537 Featured in Poster Presentations MOUNTAIN VIEW, Calif., Dec….
Kronos Bio Presents Preclinical Data Supporting Anti-Leukemic Activity of Lanraplenib in Combination with Multiple Targeted Agents in Acute Myeloid Leukemia (AML) Preclinical Models at American Society of Hematology Meeting
Lanraplenib is being evaluated in ongoing Phase 1b/2 trial in combination with gilteritinib in patients…
Kymera Therapeutics Presents Preclinical Data Demonstrating Activity of KT-253, a Selective Heterobifunctional MDM2 Degrader, in Acute Myeloid Leukemia at the American Society of Hematology Annual Meeting
A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models…
Bellicum Announces Presentation by UNC at ASH 2022 on Potential Abrogation of iC9 CAR T-Cell Toxicities with Rimiducid
HOUSTON, Dec. 11, 2022 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in…
Harpoon Therapeutics Presents Updated Interim Results at ASH 2022 for Novel T Cell Engager HPN217 in Relapsed/Refractory Multiple Myeloma
Clinically active across a wide dose range (2.15 to 24 mg) in a Phase 1…
Austin Accident Lawyer Podcast Talks Car and Truck Accidents and Insurance Claims
“Austin Accident Lawyer” Andrew Traub shares how his firm has helped their clients get past…